Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

3.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

22.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[microRNA in the Realization of Molecular Mechanisms of Lymphocyte Development and Their Malignant Transformation].

Molekuliarnaia biologiia·2026
Same author

The key role of heterochromatin in the phenotypic manifestation of the In(1)sc8 inversion disrupting the achaete-scute complex in Drosophila melanogaster.

Vavilovskii zhurnal genetiki i selektsii·2025
Same author

Transcription factor DREF regulates expression of the microRNA gene bantam in Drosophila melanogaster.

Vavilovskii zhurnal genetiki i selektsii·2024
Same author

Otu and Rif1 Double Mutant Enables Analysis of Satellite DNA in Polytene Chromosomes of Ovarian Germ Cells in Drosophila melanogaster.

Doklady. Biochemistry and biophysics·2024
Same author

Different Protein Groups Involved in Transcription Regulation in Development and Housekeeping Genes in Drosophila.

Doklady. Biochemistry and biophysics·2023
Same author

[Endocrine disorders after combined chemoradiotherapy in Hodgkin Lymphoma survivors].

Problemy endokrinologii·2023

Related Experiment Video

Updated: Oct 25, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.5K

MicroRNAs in the Myelodysplastic Syndrome.

Y A Veryaskina1,2, S E Titov2,3, I B Kovynev4

  • 1Institute of Cytology and Genetics, SB RAS, Novosibirsk, 630090 Russia.

Acta Naturae
|August 11, 2021
PubMed
Summary

Myelodysplastic syndromes (MDS) are blood cancers where microRNAs (miRNAs) play a key role. This study explores how miRNA levels predict patient survival and treatment response in MDS.

Keywords:
acute myeloid leukemiamiRNAmyelodysplastic syndrome

More Related Videos

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.9K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.8K

Related Experiment Videos

Last Updated: Oct 25, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.5K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.9K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.8K

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Myelodysplastic syndromes (MDS) are a group of blood cancers characterized by ineffective blood cell production and a high risk of transformation to acute myeloid leukemia.
  • Both genetic and epigenetic factors, including microRNAs (miRNAs), are implicated in the pathogenesis of MDS.
  • Current prognostic systems for MDS, while incorporating factors like karyotype and blast count, do not always accurately predict patient outcomes or treatment efficacy.

Purpose of the Study:

  • To investigate the role of microRNA (miRNA) expression levels as potential biomarkers in myelodysplastic syndromes (MDS).
  • To determine the correlation between specific miRNA expression profiles and the prognosis of overall survival in MDS patients.
  • To assess the relationship between miRNA expression and response to therapy in individuals with MDS.

Main Methods:

  • Analysis of microRNA (miRNA) expression levels in patients with myelodysplastic syndromes (MDS).
  • Correlation of miRNA expression data with clinical outcomes, including overall survival.
  • Evaluation of the association between miRNA expression patterns and patient response to established therapies.

Main Results:

  • Abnormal microRNA (miRNA) expression levels are observed in myelodysplastic syndromes (MDS).
  • Specific miRNA expression signatures are found to correlate significantly with overall survival in MDS patients.
  • Certain miRNA profiles are associated with differential responses to therapeutic interventions in MDS.

Conclusions:

  • MicroRNAs (miRNAs) represent promising biomarkers for refining prognosis in myelodysplastic syndromes (MDS).
  • Integrating miRNA expression analysis into existing prognostic models could enhance personalized treatment strategies for MDS.
  • Further research into miRNA-based biomarkers may improve the prediction of survival and treatment effectiveness in MDS.